Drug Database · Clinicians

Lamivudine + Nevirapine + Zidovudine

Brands: none registered under a distinct brand name (generic name only).

Anti-retroviral agent PH FDA category
Fixed-dose combination.

Rx · Prescription drug1 PH productPNF-listed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: EPIVIR is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection. US FDA label

  • Use: Nevirapine tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adults and pediatric patients 15 days and older [see Clinical… US FDA label

  • zidovudine no separate page

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Film-coated tablet: 300 mg/200 mg/150 mg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Lamivudine + Nevirapine + Zidovudine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Lamivudine + Nevirapine + Zidovudine
Package insert
NoneZidovudine + Nevirapine + Lamivudine
300mg/200mg/150mg Film-Coated TabletBy 60's in a white Opaque Round 100 CC HDPE Containers with 38 mm Neck Finish Closed with 38 mm White Opaque Polypropylene Stock Ribbed Closure with Wad having Induction Sealing Liner (Box of 1's)
Rx
AUROBINDO PHARMA LIMITED - UNIT IIIIndia
FABERCO LIFE SCIENCES INC.
DR-XY46462
Nov 23, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Formulary and coverage

Philippine National FormularyListed as Lamivudine + Zidovudine + Nevirapine
PNF listingOral: 150 mg + 300 mg + 200 mg tablet
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  2. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .